Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin) to chemotherapy improves survival in metastatic colorectal cancer (Q73894018)
Jump to navigation
Jump to search
scientific article published on 01 August 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin) to chemotherapy improves survival in metastatic colorectal cancer |
scientific article published on 01 August 2003 |
Statements
Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin) to chemotherapy improves survival in metastatic colorectal cancer (English)
1 August 2003